Ipamorelin research peptide vial

Growth & Performance Research

Ipamorelin

Explore Ipamorelin research peptide online, documented. Explore its selective growth hormone secretagogue action and safety profile.

Catalogue record
OP-875
Intended use
Research use only
Independent COA on this site
Not available

This corporate catalogue does not take orders, display prices or provide dosage instructions.

Research record

Overview

Compound name: Ipamorelin

Alternative names: N/A (commonly referenced as Ipamorelin)

Compound classification: Growth hormone–releasing peptide (GHRP)

Brief factual description:

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It is designed to stimulate endogenous growth hormone release through selective activation of ghrelin (GHS-R1a) receptors.

Mechanism of Action

Primary biological targets: Growth hormone secretagogue receptor (GHS-R1a)

Affected systems: Endocrine (growth hormone axis)

Receptor selectivity: High selectivity for GH release compared to earlier GHRPs

Downstream signaling effects:

Pulsatile growth hormone secretion via hypothalamic–pituitary axis activation without significant appetite stimulation.

Frequently asked questions

What this record can—and cannot—confirm

Is Ipamorelin approved for human use?

Ipamorelin is supplied strictly for in-vitro laboratory and research use only, not for human consumption or therapeutic use. Regulatory treatment varies by jurisdiction.

How is the purity of Ipamorelin verified?

No independent report for this specific product was available in the public migration source. Request batch-specific documentation from the authorised reseller before relying on a purity claim.

Where can I buy Ipamorelin?

Through an OnlinePeptides authorized reseller. Verify any reseller at onlinepeptides.com/verify-reseller/ before purchasing.